Isolation of Four Isomers of the 20,000 Dalton Variant of Human Pituitary Growth Hormone

A simple procedure has been developed which for the first time describes the isolation of isomers of the 20, 000 dalton variant of human growth hormone (20K hGH). From a human pituitary hormone concentrate different hGH dimers (covalently and noncova-lently linked) were enriched by chromatography on SP-Sephadex C-50, DEAE-Sepharose CL-6B and Sephadex G-100. Noncovalently-1inked dimers were split by 6 M urea into 20K hGH and 22K hGH monomers. A complete group-separation of 20K hGH and 22K hGH monomers was achieved by chromatography on DEAE-Sepharose CL-6B at neutral pH. The 20K hGH monomer was resolved into four isomers either by preparative isoelectric focusing or by zone electrophoresis in agarose suspension at alkaline pH. The three latter techniques were all used in the presence of 6 M urea. Radioimmunoassay and radioreceptorassay indicated that the isomers obtained were true components of human growth hormone.     

Water Soluble Receptors for Human Growth Hormone from Rabbit Liver

Abstract

Soluble receptors that bind human growth hormone have been prepared by incubation of liver membranes from pregnant female rabbits in 1 mM Tris buffer (pH 7.5 or 9.0) at 4°C. Up to 29% of the growth hormone binding sites could be solubilized within 48 hours. The kinetics of binding of human growth hormone to the soluble receptor, the hormonal specificity and the binding parameters calculated by Scatchard analysis (K_a 2.2 × 10⁹ M^-1, capacity 409 fmole/mg) were essentially unchanged compared with those for the parent membrane-associated (particulate) receptor. Gel filtration on Ultrogel AcA22 indicated that the major binding peak eluted at a molecular weight of 300,000 daltons. Specificity studies showed that the soluble binding sites had a moderately high affinity for ovine prolactin (K_a ～1 × 10⁸ M^-1), but negligible affinity for insulin. Although aqueous extraction gives a lower yield of binding sites for human growth hormone than detergent extraction, it nevertheless avoids some of the problems associated with use of detergents and should facilitate the subsequent purification of the receptor in a relatively unaltered state. It may also have applicability for solubilization of other hormone receptor systems.     

Effect of Fenfluramine on Human Growth Hormone Release

In order to investigate the effect of fenfluramine on hormonal and metabolic changes with exercise, five normal volunteers have been studied during and after 20 minutes of steady exercise on a bicycle ergometer after injection of fenfluramine (20 mg intravenously). Fenfluramine abolished the rise of plasma human growth hormone (HGH) which occurred in control investigations. Fenfluramine also affected plasma insulin, blood glucose, and ketone body levels.The acute effect of fenfluramine on the release of growth hormone was examined further by studying its effect in patients with acromegaly. A marked depression of growth hormone occurred both at rest and with exercise. These observations indicate that fenfluramine has a direct effect on pathways controlling growth hormone release. We also suggest that this action may have practical use in the medical treatment of acromegaly.     

Effects of Growth Hormone Administration in Human Obesity

Objective: To summarize the reports in the literature regarding the effect of growth hormone (GH) treatment of obesity. Research Methods and Procedures: Clinical trials of GH treatment of obese adults were reviewed and summarized. Specifically, information regarding the effects of GH on body fat and body fat distribution, glucose tolerance/insulin resistance, and adverse consequences of treatment were recorded. Results: GH administered together with hypocaloric diets did not enhance fat loss or preserve lean tissue mass. No studies provided strong evidence for an independent beneficial effect of GH on visceral adiposity. In all but one study, glucose tolerance during GH treatment suffered relative to placebo. Conclusion: The bulk of studies indicate little or no beneficial effects of GH treatment of obesity despite the low serum GH concentrations associated with obesity.     

人生长素基因的合成及克隆

根据人生长素基因的氨基酸序列,选择大肠杆菌所偏好的密码子,人工设计并合成了20个寡核苷酸片断。通过重叠区扩增法,利用PCR成功地合成了人生长激素基因的全序列。经克隆测序,证明已成功地实现了人生长素基因的合成及克隆。     

Isolation of Three Electrophoretic Variants of Rat Pituitary Growth Hormone

A procedure has been developed for the isolation of rat pituitary growth hormone and for the subsequent resolution of the preparation into three variants by preparative electrophoresis. The starting material was whole frozen glands and the process involved homogenization and extraction at pH 6.2, ammonium sulfate fractionation and molecular-sieve chromatography on Sephadex G-100. The separation into charge variants was achieved by zone electrophoresis in agarose suspension at alkaline pH.

The purfication was monitored by radioimmunoassay and the specific activities were expressed in terms of the rat growth hormone reference preparation (RP-1) supplied by the NIADDK, Bethesda, U. S. A.

The three-component preparation and its constituents all had activities in the same range, exceeding the activity of the reference by a factor up to 20 times. Bioassay of the three-component preparation, based on measurement of longitudinal bone growth in hypophysectomized rats gave a potency of 4–5 IU/mg. The reference was the 1st International Standard (bovine) for growth hormone. The yield of the three-component preparation was 3.3 mg per gram pituitary tissue.

Different electrophoretic analyses revealed the efficiency of the preparative procedure in separating the variants. The results of the analyses also support the view that difference in electrophoretic behaviour is due to a difference of a single net charge between adjacent variants.

In addition, growth hormone was prepared from two side extracts (at pH 7.0 and pH 9.8, respectively), provided by a procedure developed earlier for rat prolactin. The three preparations gave electrophoretic patterns of equal appearance although the relative proportions of the activity peaks differed.     

分泌型重组人生长激素工程菌发酵及其产物纯化

在 5L发酵罐中将工程菌pET-ompA3-hGH/BL21(DE3)进行补料式发酵 ,诱导表达分泌型重组人生长激素。通过对发酵培养基成分、补料成分、补料体积、补料时机和滴加流速的选择 ,分泌表达rhGH的量可达到 250mg/L ,占周质蛋白的 44%～ 54% ,发酵周期缩短为8h。用rhGH纯蛋白免疫动物制备的多克隆抗体制成的抗体亲和层析柱 ,一步纯化大肠杆菌周质中分泌表达的rhGH ,产物纯度达到96%以上 ,纯化产物在分子质量大小、免疫活性和二硫键的形成与天然生长激素相一致 。     

Synthesis of Human Growth Hormone Fragments with Growth-promoting Activity

WE have reported¹ the synthesis and growth-promoting activity of two polypeptides corresponding to the sequences 81–121 and 122–153 of the human growth hormone (HGH) proposed by Li². Studies of the HGH internal homologies and the comparison between HGH and ovine prolactin³ (OP) sequences have helped us in the recognition of somatotrophic active sites. After the primary structure revision^4,5, internal homologies of HGH and external homologies between HGH and OP emerge even more clearly.     

The Amino Acid Composition of Human Pituitary Growth Hormone

The amino acid content in human hypophyseal growth hormone has been determined by chromatography on resin columns. On the basis of 29,000 for the molecular weight, the empirical formula of the hormone was obtained: lys₁₃his₅arg₁₄asp₂₇ thr₁₄ser₂₃glu₃₄pro₁₂gly₁₃ala₁₂-(1/2 cys)₆val₁₂met₄-ileu₁₀leu₃₁tyr₁₀phe₁₅try₁(NH₃)₃₂.     

用重组大肠杆菌发酵生产人生长激素研究

通过不同培养基、不同糖浓度对重组菌Ｅ．ｃｏｌｉＤＨ１０Ｂ／ｐＩＮⅢＡ３ＨＧＨ的菌体生长与外源蛋白表达量的影响的比较，确定较为合适的培养条件，并对发酵过程中调节ｐＨ的氨水用量与外源蛋白的表达量之间的相关性作探索，得到相关性曲线，从而根据氨水用量了解细菌的生长状况。     

重组人类生长激素对胃癌细胞的体外增殖研究

目的：通过体外实验,研究重组人类生长激素对胃癌细胞的增殖的影响。方法：实验分为空白组,重组人类生长激素组,奥沙利铂组和重组人类生长激素＋奥沙利铂组。用不同浓度的重组人类生长激素处理SGC．7901细胞,采用MTT法和流式细胞仪检测人胃癌细胞株的细胞抑制率,细胞周期和DNA抑制率。结果：体外实验结果表明,重组人类生长激素对SGC．7901细胞株增殖没有明显的促进作用,重组人类生长激素组和空白组以及重组人类生长激素＋奥沙利铂组和奥沙利铂组之间没有统计显著性（P〉0．05）,细胞抑制率和停止生长的细胞在G0-G1期明显增加（P〈0．01）,同时重组人类生长激素＋奥沙利铂组和空白组以及奥沙利铂组在S期,细胞数依次下降,DNA抑制率依次增加。重组人类生长激素＋奥沙利铂组与奥沙利铂组相比,细胞抑制率有明显上升趋势。结论：体外实验表明,重组人类生长激素并不加快人类胃癌细胞的增殖,与抗癌药物一同使用时,有增加治疗功效的作用。     

重组人类生长激素对胃癌细胞的体外增殖研究

目的:通过体外实验,研究重组人类生长激素对胃癌细胞的增殖的影响。方法:实验分为空白组,重组人类生长激素组,奥沙利铂组和重组人类生长激素+奥沙利铂组。用不同浓度的重组人类生长激素处理SGC-7901细胞,采用MTT法和流式细胞仪检测人胃癌细胞株的细胞抑制率,细胞周期和DNA抑制率。结果:体外实验结果表明,重组人类生长激素对SGC-7901细胞株增殖没有明显的促进作用,重组人类生长激素组和空白组以及重组人类生长激素+奥沙利铂组和奥沙利铂组之间没有统计显著性(P>0.05),细胞抑制率和停止生长的细胞在G0-G1期明显增加(P<0.01),同时重组人类生长激素+奥沙利铂组和空白组以及奥沙利铂组在S期,细胞数依次下降,DNA抑制率依次增加。重组人类生长激素+奥沙利铂组与奥沙利铂组相比,细胞抑制率有明显上升趋势。结论:体外实验表明,重组人类生长激素并不加快人类胃癌细胞的增殖,与抗癌药物一同使用时,有增加治疗功效的作用。     

Expression of Human Growth Hormone by the Eukaryotic Alga, Chlorella

A method to use Chlorella to express a recombinant heterologous protein that can be recovered from the extracellular medium has been developed. Plasmids are constructed with an extracellular secretion signal sequence inserted between a promoter region and a gene for human growth hormone (hGH). The plasmids also contain a Kan^r region which confers resistance to the antibiotic G418. Protoplasts are prepared by enzymatic treatment, and the plasmid is introduced by incubation of the protoplasts with polyethylene glycol and dimethyl sulfoxide. Cells are then grown in the presence of G418, and the medium is collected from 6 days after transfection. hGH is measured by immunoassay, and values for expressed hGH of about 200–600 ng/ml are obtained. Received: 5 November 1998 / Accepted: 25 January 1999     

Isolation of Human Hepatocytes by a Two-step Collagenase Perfusion Procedure

The liver, an organ with an exceptional regeneration capacity, carries out a wide range of functions, such as detoxification, metabolism and homeostasis. As such, hepatocytes are an important model for a large variety of research questions. In particular, the use of human hepatocytes is especially important in the fields of pharmacokinetics, toxicology, liver regeneration and translational research. Thus, this method presents a modified version of a two-step collagenase perfusion procedure to isolate hepatocytes as described by Seglen ¹.Previously, hepatocytes have been isolated by mechanical methods. However, enzymatic methods have been shown to be superior as hepatocytes retain their structural integrity and function after isolation. This method presented here adapts the method designed previously for rat livers to human liver pieces and results in a large yield of hepatocytes with a viability of 77±10%. The main difference in this procedure is the process of cannulization of the blood vessels. Further, the method described here can also be applied to livers from other species with comparable liver or blood vessel sizes.     

A Rapid One-Step Extraction Procedure for the Isolation of Ubiquitin from Human Erythrocytes for Antibody Production

Abstract

A procedure is described that employs 5% perchloric acid extraction to isolate ubiquitin from human erythrocytes. The procedure is rapid and economical as it requires no specialized equipment. The extracted protein appeared to be highly purified as judged by electrophoresis and was identified as ubiquitin by immunoblotting and total amino acid analysis. The extraction yields about 78% of the ubiquitin in the hemolysate, which is a higher yield than is obtained with other procedures. The purified ubiquitin was used to make a polyclonal antiserum. As ubiquitin is a small and highly conserved protein, it is necessary to couple it to a larger immunogen to elicit an immune response. This ubiquitin antiserum was produced using an immunogen system that produces an immune response to the ubiquitin, but not to the carrier protein.     

Gel Electrophoretic Procedures Potentially Applicable to the Isolation of Human Growth Hormone from A Transformed Bacterial Source at the Gram-Preparative Scale

A crude bacterial extract containing approximately 4 mg/ml protein, 25% of which was human growth hormone (hGH), was subjected to two alternative gel electrophoret ic isolation procedures, designated I and II. Procedure I exploits the high electrophoretic net mobility (RM² larger than 0.127) at pH 7.6, 0°C, of the bacterial contaminants relative to hGH. This allows one to stack ³ the contaminants at a protein load of 31.5 mg/cm² of gel, using a “non-restrictive” gel concentration. Unstacked hGH is collected from the gel section between 0.3 and 0.6 of relative gel length and extracted electrophoretically as described previously⁴ Alternatively, the unstacked hGH was concentrated on the gel by dispatching a second moving boundary behind the original stack (“re-stacking”) and a gel section (relative gel length 0.45 to 0.6) between the two moving boundaries was excised and subjected to electrophoretic extraction. The yield of hGH ranged from 70 to 82%, and its purity (weight/Lowry) ranged from 86 to 115%. Procedure II exploits the high electrophoretic net mobility (RM larger than 0.064) at pH 10.5, 0°C, of hGH relative to its bacterial contaminants at a gel concentration of 9 %T, 2 %C_. ², at a protein load of 2.5 mg/cm² of gel. The selectively stacked hGH is collected by preparative elution-PAGE, using an apparatus with 17.6 cm² gel surface area. The yield of hGH was 90% and its purity ranged from 84–92%.     

肥胖症的重组人生长激素治疗探讨

本文叙述了肥胖症的病因,诊断标准及重组人生长激素治疗ＰｒａｄｅｒＷｉｌｉ综合征和成人肥胖症的探讨     

利用重组大肠杆菌生产人生长激素发酵工艺的研究

在摇瓶培养和发酵罐培养条件下,研究了E.coli/BL21(DE3)/pET30a(+)-hGH工程菌的不同发酵工艺条件。确立了该工程菌的最优化工艺参数:M9-2培养基,37℃、pH值为6.8-7.4、诱导起始菌体密度为OD600达3.0-4.0,IPTG浓度为1mmol/L,诱导时溶氧控制为50%以上,补料为10%甘油、5%Yeast extract和5%Tryptone。该工艺条件经过连续三批发酵,证实稳定可行,目的蛋白在胞间质呈可溶性表达,表达量占菌体总蛋白的20%以上。     

重组人生长激素的主要药效学研究

参照文献方法,观察了ｒｈＧＨ对正常大鼠（３月龄,平台期）生长发育作用的影响,ｉｍ,ｒｈＧＨ（０．０５、０．１５、０．４５ｍｇ．ｋｇ＾－１．ｄ＾－１）,连续１５天,结果表明：ｒｈＧＨ（０．１５、０．４５ｍｇ．ｋｇ＾－１．ｄ＾－１）同阳性对照生长激素ＮＩＢＳＣ标准品）一样,均可明显促进正常平台期大鼠的体重及尾长增加,大剂量组还可明显促进肝、肾及骨骼的生长发育,使肝、肾重量增加,胫骨骨骺端距离增大,同